Key clinical point: Regular monitoring of treatment response is needed, particularly when pangenotypic treatment is not used.
Major finding: Researchers detected 4.4% mixed HCV genotype infections.
Study details: Virus fragments were sequenced from 50 HIV+ and 18 HIV– patients recently infected with HCV.
Disclosures: The study was funded by the French government; the authors reported having no conflicts.
Nguyen T et al. Int J Antimicrobial Agents. 2019. 54:523-7.